---
mi_id: MIPR-node_f0c009f
type: press_release
canonical_url: "https://www.pheonixresearch.com/agriculture-agritech/crop-protection-pest-control/press-release/crop-protection-4-12-per-cent-herbicides-47-per-cent-of-value-35-per-cent-of-growth/"
md_url: "https://www.pheonixresearch.com/agriculture-agritech/crop-protection-pest-control/press-release/crop-protection-4-12-per-cent-herbicides-47-per-cent-of-value-35-per-cent-of-growth.md"

schema:
  "@type": NewsArticle
  "@id": MIPR-node_f0c009f
  url: "https://www.pheonixresearch.com/agriculture-agritech/crop-protection-pest-control/press-release/crop-protection-4-12-per-cent-herbicides-47-per-cent-of-value-35-per-cent-of-growth/"
  title: "Crop Protection Grew 4.12 Per Cent on 1.88 Per Cent More Product and 2.20 Per Cent More Price — and Herbicides, 47 Per Cent of the Value, Supply 35 Per Cent of the Increase"
  description: "Global crop protection was USD 72.40bn in 2025 and reaches USD 100.00bn by 2033 at 4.12%. Volume grows 1.88% a year and value per kg of active ingredient 2.20%. Herbicides are 47.0% of value and 34.7% of the growth; biologicals 4.6% and 15.1%."
  datePublished: "2026-11-16T12:34:16+00:00"
  dateModified: "2026-11-16T12:34:16+00:00"
  keywords:
    - crop protection market
    - agrochemicals market
    - pesticide market
    - herbicides market share
    - biologicals market
    - glyphosate price
    - Brazilian distributor insolvency
    - crop protection forecast 2033
  isPartOf:
    - id: MISG-node_92c683e
      type: CollectionPage
      url: "https://www.pheonixresearch.com/agriculture-agritech/crop-protection-pest-control/"
      name: "Crop Protection & Pest Control"
    - id: MIIN-node_25bc9e9
      type: CollectionPage
      url: "https://www.pheonixresearch.com/agriculture-agritech/"
      name: "Agriculture & Agritech"
    - id: MIWS-root
      type: WebSite
      url: "https://www.pheonixresearch.com/"
      name: Pheonix Research

acf:
  phoenix_meta_title: "Crop Protection: 4.12% Growth, 47% Herbicides, 35% of the Increase"
  phoenix_meta_description: "Global crop protection was USD 72.40bn in 2025 and reaches USD 100.00bn by 2033 at 4.12%. Volume grows 1.88% a year and value per kg of active ingredient 2.20%. Herbicides are 47.0% of value and 34.7% of the growth; biologicals 4.6% and 15.1%."

global_schema:
  organization:
    "@id": MIWS-root#organization
    "@type": Organization
    url: "https://www.pheonixresearch.com/"
    name: Pheonix Research
  website:
    "@id": MIWS-root
    "@type": WebSite
    url: "https://www.pheonixresearch.com/"
    name: Pheonix Research
  api:
    "@id": MIWS-root#api
    "@type": WebAPI
    url: "https://www.pheonixresearch.com/"

graph:
  node_id: MIPR-node_f0c009f
  graph_node_endpoint: "https://graph.pheonixresearch.com/api/v1/query/live/node/MIPR-node_f0c009f"
  graph_snapshot: "https://graph.pheonixresearch.com/api/v1/read/live/graph"
  graph_exclusions: "https://graph.pheonixresearch.com/api/v1/read/live/exclusions"
  graph_meta: "https://graph.pheonixresearch.com/api/v1/read/live/meta"
  graph_bundle: "https://graph.pheonixresearch.com/api/v1/read/live/bundle"

discovery:
  discovery_json: "https://www.pheonixresearch.com/.well-known/pheonix-discovery.json"
  llms_txt: "https://www.pheonixresearch.com/llms.txt"
  sitemap: "https://www.pheonixresearch.com/sitemap.xml"
---
# Crop Protection Grew 4.12 Per Cent on 1.88 Per Cent More Product and 2.20 Per Cent More Price — and Herbicides, 47 Per Cent of the Value, Supply 35 Per Cent of the Increase

The global crop protection market — herbicides, fungicides, insecticides, nematicides, biologicals and the rest of plant protection chemistry, valued at manufacturer selling prices — was worth **USD 72.40 billion in 2025** and reaches **USD 100.00 billion by 2033**, a **4.12 per cent compound annual growth rate**.

Take it apart and the number stops being unremarkable. Volume rises from **4.05 million to 4.70 million tonnes of active ingredient**, **1.88 per cent a year**. Value per kilogram of active ingredient rises from **USD 17.88 to USD 21.28**. Of the **USD 27.60 billion** the market adds, **USD 12.70 billion is more product and USD 14.90 billion is more money for the same kilogram** — 46 per cent and 54 — and the two compound to 4.12 exactly.

That the arithmetic closes is worth saying at the outset, because what it closes over is a decade of falling prices. FAO records global agricultural pesticide use at **3.92 million tonnes of active ingredient in 2024**: up 5 per cent on 2023, up 18 per cent in a decade, and more than double the 1990 level. Over the same 2015–2024 window the **volume of internationally traded pesticides rose 53 per cent while their value rose 35 per cent**. Read as a unit price, that is an **11.8 per cent decline in nominal dollars over ten years** — across the most authoritative dataset there is, in a market that applied more product in every one of those years.

This is the only major agricultural input in our coverage where the value of the category has fallen while the tonnage applied has risen. It is why a forecast built on feeding ten billion people will be wrong by a wide margin, and it is why the published range for the 2025 market runs from roughly **USD 50 billion to USD 88 billion** — a disagreement about scope, not about arithmetic.

Global crop protection market value, 2025–2033. Growth is 46 per cent volume and 54 per cent price and mix.

## Why the size is 72.40 and not 50 or 88

Three boundary decisions create the published spread: whether post-patent technical material sold by Chinese and Indian producers to formulators is inside the count; whether seed treatment and biologicals belong to crop protection or to seeds; and whether value is measured at the manufacturer or at the farm gate. Roughly two-thirds of the world's active ingredient tonnage is now made by companies that did not discover it. Counting only branded, innovator-sold product measures the pricing power of four companies. Counting manufacturer-level revenue including the generic tier measures the market.

This report measures the market, triangulated from three directions that share no data source. **Bottom-up** from five disclosed segments: Syngenta Crop Protection **USD 13.70 billion**; Bayer crop protection **EUR 10,486 million** at EUR/USD 1.13, being **USD 11.85 billion**; BASF **EUR 6,986 million = USD 7.89 billion**; Corteva **USD 7.50 billion**; FMC **USD 3.47 billion**. The five total **USD 44.41 billion**. **Share reconciliation:** that is 60 to 64 per cent of the manufacturer-level market once the generic tier is counted, implying **USD 69.4 to 74.0 billion**. **Volume cross-check:** a USD 69 to 75 billion market over 4.05 to 4.11 million tonnes implies **USD 17,000 to 18,500 per tonne of active ingredient**, which is what a herbicide-weighted, post-patent mix produces.

The three converge on a band of **USD 69.5 to 75.5 billion**. The midpoint is taken. That choice makes the number larger than most published estimates and the growth rate lower than most published forecasts, and the two are the same decision.

## Share of value is not share of growth

 | **Product class** |  | **2025 (USD mn)** |  | **Share** |  | **2033 (USD mn)** |  | **CAGR** |  | **Share of the growth** |

 | Herbicides |  | 34,028 |  | 47.0% |  | 43,600 |  | 3.15% |  | 34.7% |

 | Fungicides |  | 19,765 |  | 27.3% |  | 28,300 |  | 4.59% |  | 30.9% |

 | Insecticides and nematicides |  | 13,756 |  | 19.0% |  | 19,200 |  | 4.26% |  | 19.7% |

 | Biologicals |  | 3,330 |  | 4.6% |  | 7,500 |  | 10.68% |  | 15.1% |

 | Other crop protection |  | 1,521 |  | 2.1% |  | 1,400 |  | −0.98% |  | −0.4% |

 | **Total** |  | **72,400** |  | **100.0%** |  | **100,000** |  | **4.12%** |  | **100.0%** |

The two ends of that table are the report. Herbicides are **47.0 per cent of 2025 value and supply 34.7 per cent of the USD 27.60 billion the market adds**. Biologicals are **4.6 per cent of value and supply 15.1 per cent of the increase**. Fungicides are 27.3 and 30.9. Insecticides and nematicides are 19.0 and 19.7. The residual class — plant growth regulators, fumigants, molluscicides and rodenticides — shrinks, driven almost entirely by fumigant phase-out under the Montreal Protocol and by its replacements being lower-volume, higher-value products.

Herbicides are the slowest-growing class at 3.15 per cent for a structural reason rather than a cyclical one: they are the most commoditised, the most exposed to glyphosate and glufosinate pricing, and the class where generic substitution is fastest. They are also the class that took the 2024 dicamba vacatur, which removed an entire over-the-top system rather than a single product.

Product-class split of the 2025 crop protection market. Herbicides are 47.0 per cent of value and the slowest-growing class at 3.15 per cent.

## The same inversion, geographically

 | **Region** |  | **2025 (USD mn)** |  | **Share** |  | **2033 (USD mn)** |  | **CAGR** |  | **Share of the growth** |

 | Latin America |  | 21,070 |  | 29.1% |  | 29,600 |  | 4.34% |  | 30.9% |

 | Asia-Pacific |  | 18,970 |  | 26.2% |  | 29,000 |  | 5.45% |  | 36.3% |

 | North America |  | 16,720 |  | 23.1% |  | 22,000 |  | 3.49% |  | 19.1% |

 | Europe |  | 13,100 |  | 18.1% |  | 15,600 |  | 2.21% |  | 9.1% |

 | Middle East and Africa |  | 2,530 |  | 3.5% |  | 3,800 |  | 5.22% |  | 4.6% |

 | **Total** |  | **72,400** |  | **100.0%** |  | **100,000** |  | **4.12%** |  | **100.0%** |

Asia-Pacific is **26.2 per cent of value and supplies 36.3 per cent of the growth** at 5.45 per cent. Latin America is the largest region at **29.1 per cent of value and 30.9 per cent of the growth** at 4.34. Europe is **18.1 per cent of value and 9.1 per cent of the growth** at 2.21. The region with the highest value per hectare is not the region growing fastest, and the region with the fastest volume growth earns a fraction of the price per hectare. A supplier has to be in both to grow.

Latin America carries the highest value per hectare because Brazilian and Argentine soybean and cotton systems are the most input-intensive in the world and because disease pressure in a tropical growing system is continuous rather than seasonal. It also carries the most fragile channel, which is why it grows below Asia-Pacific despite holding twice the value per hectare.

## The price is set in China, and it fell again this year

Glyphosate is the price index for the whole category because it is the largest single active by volume and the most commoditised. Ninety-five per cent technical traded at **RMB 26,101 per tonne on 28 November 2025**, down RMB 1,000 in a month, with port reference prices at **USD 3,700 to 3,730 per tonne FOB**. In January 2025 the same grade was offered at RMB 24,000 to 24,300. Glyphosate therefore spent 2025 recovering modestly from a trough and then rolled over again in the fourth quarter.

A floor that holds and a ceiling that does not is what structurally excess capacity looks like. China exported **2.303 million tonnes** of pesticides in 2025 worth **RMB 126.83 billion**, up 12.2 per cent in volume and 11.9 per cent in value — value growth behind volume growth, which is the definition of supply chasing rather than leading demand. At **RMB 55,072 a tonne** on average, the export price fell again.

The mechanism is not a demand cycle. A producer running a multi-product plant recovers fixed cost by running volume, and the incentive to withhold output and defend price is weaker than the incentive to keep the plant loaded. Chinese capacity added during the 2021–22 shortage has not been retired and there is no mechanism for retiring it. ICAMA has now moved to permit registration of active ingredients for **export only** — a molecule not registered for use inside China can be registered for export — and to relax restrictions on formulation ratios and content levels to meet overseas specification. Both changes convert Chinese producers from suppliers of technical material into suppliers of finished, specified product.

The forecast is a specific bet that this structure persists, and it should be read that way. Anyone forecasting 6 per cent is forecasting either a return to 2022 pricing, which requires the capacity to exit, or volume growth of 4 to 5 per cent, which no measured decade of FAO data supports.

## In the worst pricing year in a decade, three of the four held margin. The fourth did not.

 | **Company** |  | **Crop protection revenue 2025** |  | **Growth** |  | **Margin signal** |

 | Syngenta Crop Protection |  | USD 13.70bn |  | +4% (+3% CER) |  | Volumes up, pricing pressure in Brazil and Latin America |

 | Bayer Crop Protection |  | EUR 10,486m (USD 11.85bn) |  | Core crop protection −4% currency-adjusted |  | Crop Science EBITDA margin before special items 19.4%, held flat |

 | BASF Crop Protection |  | EUR 6,986m (USD 7.89bn) |  | Volume +3.0%, price −1.2%, currency −3.9% |  | Agricultural Solutions EBITDA +7.4% on sales −2.2% |

 | Corteva Crop Protection |  | USD 7,503m |  | +2% (+3% organic) |  | EBITDA USD 1,350m, +6%, margin +70bp |

 | FMC |  | USD 3,470m |  | −18% (−8% excluding India) |  | Adjusted EBITDA USD 843m, −7% |

 | UPL |  | INR 466.4bn (about USD 5.49bn) |  | +8% |  | EBITDA INR 81.2bn, +47%, margin 17.4% |

The four largest suppliers hold about **56.6 per cent** of this market on USD 40.94 billion of crop protection revenue; adding FMC takes the top five to USD 44.41 billion, or 61.3 per cent. That concentration is high in absolute terms and it is **falling** — the four-firm share exceeded 60 per cent a decade ago, and the drift is not the leaders losing their products. All four grew or held revenue in 2025 on a constant-currency basis. It is the generic tier growing faster, because the marginal tonne of active ingredient is made by a company that did not discover it and is not carrying the discovery cost.

**Bayer's product line moved further than its total did.** Core crop protection fell 4 per cent currency-adjusted, but within it fungicides fell 4.8 per cent to EUR 2,888 million and insecticides fell **12.2 per cent** to EUR 1,369 million — roughly EUR 190 million of revenue removed, almost entirely by one registration expiring in Europe. Non-glyphosate herbicides rose 0.5 per cent and glyphosate-based herbicides were flat at EUR 2,552 million. That is a European administrative event with a worldwide income statement consequence.

**BASF made more money on less revenue.** Volumes rose 3.0 per cent, prices fell 1.2 and currency took another 3.9, yet EBITDA before special items rose 7.4 per cent to **EUR 2,081 million** on sales of EUR 9,587 million, down 2.2 per cent — attributed to reduced manufacturing cost and to the launch of glufosinate-P-ammonium. That is what a portfolio does in a deflationary market: it substitutes volume for price and lets cost come out.

**Corteva's mix is the most defensible.** Volume plus 5 against price minus 2 is the healthiest spread in the group, and it came with crop protection EBITDA of **USD 1,350 million, up 6 per cent and about 70 basis points of margin**. It is also the only one of the four that discloses biologicals separately: **USD 519 million, up 9 per cent, 6.9 per cent of its crop protection revenue** — the only audited, segment-level data point in the fastest-growing class in this report.

**FMC is the cautionary case.** Revenue fell **18 per cent** to USD 3.47 billion and **8 per cent even excluding the Indian business it is selling**, while adjusted EBITDA fell only 7 per cent to USD 843 million — the signature of a company cutting cost faster than it is losing revenue. Its response is the template for the second tier: Project Foundation to exit high-cost production sites, two active ingredients moved to lower-cost manufacturing locations, the Indian commercial business put up for sale with completion anticipated in 2026, and a direct sales and technical service organisation built in Brazil to sell straight to large corn and soybean growers.

Read as one strategy, that is a company concluding that ownership of manufacturing, patents and the last mile is defensible, and that ownership of a distribution business in the world's most price-destroyed market is not.

## The balance-sheet risk moved to the distributor, and the manufacturer is underwriting it

Brazil is the single largest national crop protection market on earth, and its distribution tier went through a genuine solvency event. AgroGalaxy filed for judicial recovery in **September 2024**. Lavoro agreed an extrajudicial recovery with creditors in **June 2025**, having cut its own guidance after describing a significant tightening in inventory financing conditions across the sector, on a **USD 48.2 million first-quarter loss**. Both had expanded through acquisition on borrowed money into a falling commodity price environment and then met a high interest rate cycle.

The clean piece of evidence that this has become a supplier problem is Corteva's own language: its SG and A increase is attributed to higher compensation *and bad debt*. FMC's exit from India was justified partly on substantial working capital requirements — the same constraint seen from the other end. The intermediary is a bank with a warehouse; its cost of capital is an input to the price of a fungicide; and when it cannot finance a season, the manufacturer finances it or loses the sale.

That is why the 2026 recovery in this forecast is **3.7 per cent** rather than the 5 a simple inventory rebuild would imply, and why channel ownership has become a competitive weapon rather than a distribution choice. A manufacturer that sells through a distributor sells a product. A manufacturer that has to finance the channel is selling credit, and credit is a business with a different cost of capital and a different set of competitors.

## Regulation is a revenue line, not a risk factor — and the largest change of the period is deflationary

Both of 2024's largest revenue shocks were court rulings that no trend line anticipated.

On **6 February 2024** the US District Court of Arizona vacated the registrations for the over-the-top dicamba products XtendiMax, Engenia and Tavium; the EPA's existing-stocks order of 14 February limited the damage to one season without restoring the product. The damage did not stay in the herbicide line. Bayer's soybean seed and traits revenue fell **7.7 per cent** currency-adjusted to EUR 2,214 million and cotton seed fell **22.9 per cent** to EUR 442 million, both attributed principally to the vacatur. Removing a herbicide removed the reason to buy the seed that tolerates it, and the seed loss was larger than the herbicide loss. Chemistry and germplasm are now one product, which is why a district court ruling is a revenue event.

In Europe the Commission **withdrew** its Sustainable Use Regulation proposal on **27 March 2024**, leaving Directive 2009/128/EC as the operative framework and a 50 per cent reduction target formally in place with no binding instrument to deliver it. What remains is continuous attrition, active by active, which is why the European forecast is **2.21 per cent**, the slowest of any region, on policy rather than agronomy.

And the largest regulatory change of the period runs the other way. Brazil's **Lei nº 14.785**, sanctioned on **27 December 2023**, concluded a legislative process that had run twenty-four years, moved the registration standard from hazard assessment to risk analysis, and set a maximum registration period of **two years** for new pesticides against a prior average of **eight to ten**. That lowers the cost of entering the world's largest crop protection market with a copy. The law that improves grower access improves the generic tier's economics more than the branded tier's, and it is deflationary.

## What the industry is doing about it: sell systems, not molecules

The strategic answer has been to stop selling actives and to start selling systems. A premix of two proprietary actives, or a co-pack of a chemical with a biological, is a product the generic tier cannot legally copy at the same specification, and it competes on agronomic outcome rather than on price. The premix is the single most important product trend in this market, it is invisible in a product-class table, and it explains most of the rise from USD 17.88 to USD 21.28 a kilogram.

It also makes registration throughput a revenue driver, because every additional approved active is a new combination a company is entitled to sell. Syngenta counted **more than 1,800 approvals in 2025** including re-registrations and label extensions. Its PLINAZOLIN technology reached US EPA approval for five insecticide products after **twelve years of research and more than 3,000 US trials**. TYMIRIUM gained registrations in Canada, Australia, the United States and Brazil. Corteva's three newest actives — fluindapyr, Isoflex and Dodhylex — reached approximately **USD 200 million of sales, up 54 per cent**. BASF states a pipeline targeting more than **EUR 7.5 billion** of sales from products launched by 2034.

That is genuine, patented, differentiated chemistry and it earns a real premium. What it does not do is grow the market at 6 per cent, because a new active arrives into a market where the grower's alternative is a generic version of the molecule it was designed to replace. The premium is measured from the generic price, not from the previous branded one, and it is smaller than the industry's pricing model assumed for thirty years.

The honest note on biologicals belongs here. They are **4.6 per cent of this market and reach 7.5 per cent by 2033 at 10.68 per cent**, and that base is Corteva's audited USD 519 million extrapolated across a market where only one of the four majors breaks the line out — a deliberate choice to understate. Several published figures for biopesticides or agricultural biologicals are larger than this market's entire insecticide class, because they include biostimulants, biofertilisers and soil amendments, which are not pest control. Our Agricultural Biologicals report sizes that adjacent pool separately and models its biopesticide component at 10.2 per cent; the difference from 10.68 here is a different base rather than a disagreement, and both pages say so.

## The valuation has already been marked down. The operations have not.

Bayer's Crop Science division reported EBITDA of **negative EUR 1,585 million** for 2025 against EBITDA before special items of **positive EUR 4,188 million** — a gap of **EUR 5,773 million** of special items, on a division with EUR 21.6 billion of sales. Its profitability before special items held at **19.4 per cent for the second year**.

Those two sentences together are the state of this industry. Operations are fine. The valuation premise is not. The cash flows this sector was valued on in 2018 are not the cash flows it produces in 2025, and the difference is not a demand problem — it is that the reference price moved to a plant in China.

On the other side of the ledger, UPL completed a full balance-sheet repair in twelve months: revenue up 8 per cent to **INR 466.4 billion**, EBITDA up 47 per cent to **INR 81.2 billion**, margin up 460 basis points to 17.4 per cent, and net debt down **INR 83.2 billion** to INR 138.6 billion, after a FY2024 loss of INR 12.0 billion. That was achieved through deleveraging and working capital discipline rather than through price — the only lever available to a company without proprietary chemistry.

## Against the market beside it

Crop protection is **42.0 per cent of the value** of the fertiliser market we size separately at USD 172.38 billion, and roughly **twenty-two times the price per tonne**: USD 17,877 a tonne of active ingredient against USD 825 a nutrient tonne. The cheaper input by the tonne decides what the dearer one is worth per hectare, because a grower who cuts fertiliser rate cuts the yield the fungicide programme is protecting.

What the two markets share is a price set outside the companies that make the product — gas and export licences in fertiliser, capacity utilisation and export registration in crop protection. What separates them is that fertiliser price mean-reverts against energy, and crop protection price does not revert against anything, because there is no retirement mechanism for the capacity that set it.

## Scope, method and the four boundary calls

**Inside:** herbicides, fungicides, insecticides, acaricides, nematicides, molluscicides, rodenticides, fumigants, plant growth regulators and biological crop protection products, at manufacturer selling prices before distributor margin. **Outside, deliberately:** seed treatment, which is sized separately in our Seeds coverage and would add roughly USD 6 to 7 billion if folded in; fertilisers, which belong to a different industry with a different cost curve; biostimulants and biofertilisers, which are frequently bundled into biologicals by other houses and are not pest control; and seed-applied trait fees, which are a licensing charge on germplasm rather than a crop protection product.

Volume is expressed in **thousand tonnes of active ingredient**, not formulated product, because formulated tonnage is not additive across product classes — a kilogram of a 200 g/L emulsifiable concentrate and a kilogram of an 80 per cent water-dispersible granule describe nothing comparable. The value-per-kilogram series is therefore a derived indicator of mix and pricing rather than an observable transaction price, and it is presented as such. Currency is EUR/USD 1.13 and INR 85.0/USD for 2025. Company figures are full year ended 31 December 2025 except UPL, whose fiscal year ends 31 March 2025. FAO use and trade data are the 2024 release, the latest available.

No licensed third-party market study sits under this number. Entity mappings were verified individually against the Wikidata API before assignment rather than assumed, and two commonly circulated identifiers were found to be wrong in the process — one resolving to a carcinogen and one to a chemist who died in 1942 — and neither was used.

## Read the full report

**[Global Crop Protection Market Report, Size, Share and Forecast 2026–2033](https://www.pheonixresearch.com/agriculture-agritech/crop-protection-pest-control/market-report/global-crop-protection-market/)** — the full forecast table, the competitive benchmarking and company profiles, the value chain and where the margin actually sits, the regulatory chapter across the US, the EU, Brazil, China and India, the investment and divestment cycle, the seven-risk market analysis and the watch list.

**Further reading in this cluster:**

- Global Agricultural Biologicals (Biopesticides and Biostimulants) Market Report 2026–2033 — USD 13.45 billion to USD 27.50 billion at 9.35 per cent, and the segment that made biologicals normal is the one that cannot be monetised.

- Global Fertiliser (NPK) Market Report 2026–2033 — USD 172.38 billion to USD 224.00 billion at 3.33 per cent, three nutrients priced by a gas market, an export licence and a mine schedule.

- Inoculants on 40 Per Cent of Brazil's Biological Area Earn R$10.4 a Hectare Against R$54.1 for Biofungicides.

- Fertiliser Grew 3.33 Per Cent a Year. Its Three Nutrients Are Priced by a Gas Market, an Export Licence and a Mine Schedule.

- Global Seed Treatment Market Report 2026–2033 — the input this report deliberately excludes, and the only one sold before the seed is sold.

## About Pheonix Research

Pheonix Research publishes primary-sourced market intelligence through its VALUE platform. Base years are triangulated from company disclosures, government statistics and trade data rather than licensed from a third-party study, and the method is disclosed in full so that a reader can disagree with it precisely. Every figure in this release is drawn from the published report or derived from its tables.
